Case Study: Zilico

Total amount raised for this investment round.


Total amount of investors for this investment round.


Average amount invested for this investment round (Including external investments).


In June 2016, VentureFounders successfully supported Zilico in its £1.8 million equity raise, alongside angel investors and existing shareholders. 

Zilico designs and manufactures the next generation of medical diagnostic devices that remove subjectivity, increase accuracy and deliver results in real-time to clinical screening programmes, globally.

The company has developed its patented Electrical Impedance Spectroscopy (EIS) into a platform technology for cancer diagnosis, including Zilico's flagship product ZedScan™ (cervical cancer diagnostics).

The company will be using the funds to further drive commercial adoption of ZedScan and expand its product development into other clinical areas.


  • Disruptive technology that increases scanning accuracy for cervical cancer

  • Global market opportunity and robust business model

  • Product validated by industry experts

  • Experienced management team with industry expertise